PD-L1 expression on DCs can attenuate the anti-tumor effects of effector T cells by interacting with PD-1 on the surface of T lymphocytes to induce T-cell apoptosis, anergy, and exhaustion [40]. This evidence concerns the gene CD274 and neoplasm.